Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.85
0.095.11%
At close: -
$1.84
-0.00930-0.50%
After Hours: Mar 21, 7:54 PM EDT
Comments
Loading...
Longeveron (LGVN) Forecast
NewsEarningsLongeveron (LGVN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Longeveron Stock Price, Quotes and Forecasts | NASDAQ:LGVN | Benzinga
Explore Longeveron stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LGVN.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Longeveron (LGVN) stock?
You can purchase shares of Longeveron (NASDAQ:LGVN) through any online brokerage.
Who are Longeveron (LGVN) competitors?
Other companies in Longeveron’s space includes: Estrella Immunopharma (NASDAQ:ESLA), Intensity Therapeutics (NASDAQ:INTS), Curis (NASDAQ:CRIS), Coeptis Therapeutics (NASDAQ:COEP) and Nanoviricides (AMEX:NNVC).
What is the forecast, or price target, for Longeveron (LGVN) stock?
Longeveron has a consensus price target of $10.20.
What is the current price for Longeveron (LGVN)?
The stock price for Longeveron (NASDAQ: LGVN) is $1.8407 last updated March 21, 2025 at 7:54 PM EDT.
Does Longeveron (LGVN) pay a dividend?
There are no upcoming dividends for Longeveron.
When is Longeveron (NASDAQ:LGVN) reporting earnings?
Longeveron’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
Is Longeveron (LGVN) going to split?
There is no upcoming split for Longeveron.
What sector and industry does Longeveron (LGVN) operate in?
Longeveron is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.